Discover

GLP
Global Partners LP
49.37
200 x 49.11
400 x 51.00
bid
ask
+
1.41
2.94%
300 @ 05:01 PM
50.33 +0.96 (1.94%)
Ytd17.97%
1y10.92%
47.97
day range
50.05
39.58
52 week range
54.07
Open48.13Prev Close47.96Low47.97High50.05Mkt Cap1.67B
Vol120.87KAvg Vol68.04KEPS5.04P/E9.80Forward P/E19.67
Beta1.11Short Ratio4.05Inst. Own52.16%Dividend3.12Div Yield6.51
Ex Div Date08-10Earning11-0650-d Avg49.86200-d Avg47.521yr Est45.00

GLP News

GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution
marketwatch.com
GLP-1s could offer unexpected relief from back and knee pain, but doctors urge caution

Rapid weight loss can lead to issues with bone quality, particularly in older adults.

Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology
prnewswire.com
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Deli

Milestone advances the technology behind Hydreight's strategic investment and previously announced U

Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform
prnewswire.com
Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1

Milestone advances portfolio company's intellectual-property foundation for InsuTab™ and BuccaGLP™,

Zacks Industry Outlook Western Midstream, Global Partners and NGL Energy Partners
zacks.com
Zacks Industry Outlook Western Midstream, Global Partners and NGL Energy Partners

Western Midstream, Global Partners and NGL Energy Partners have been highlighted in this Industry Ou

Refining & Marketing MLP Industry Shines: 3 Stocks to Watch
zacks.com
Refining & Marketing MLP Industry Shines: 3 Stocks to Watch

Following a careful analysis of the Zacks Oil and Gas - Refining & Marketing MLP industry, we advise

Eli Lilly: Buy The GLP-1 Growth Premium
seekingalpha.com
Eli Lilly: Buy The GLP-1 Growth Premium

Eli Lilly is building a dominant obesity and diabetes treatment portfolio, positioning itself as a h

FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
prnewswire.com
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeut

New approach proposes an alternative to repeated injections HOUSTON, Oct. 7, 2026 /PRNewswire/ -- Fi

Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?
fool.com
Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?

Novo Nordisk rose dramatically because investors were excited after it launched the first GLP-1 weig

GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
thenewswire.com
GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications

Oral GLP-1 market projected to expand from $5.1 billion in 2026 to $89 billion in 2034  Novo announc

Critical Analysis: Global Partners (NYSE:GLP) and EQT (NYSE:EQT)
defenseworld.net
Critical Analysis: Global Partners (NYSE:GLP) and EQT (NYSE:EQT)

EQT (NYSE: EQT - Get Free Report) and Global Partners (NYSE: GLP - Get Free Report) are both energy

MichaelAaron Flicker on How GLP-1s Change Food Industry & Household Dynamics
youtube.com
MichaelAaron Flicker on How GLP-1s Change Food Industry & Household Dynamics

MichaelAaron Flicker, founder and CEO of XenoPsi Ventures, walks through the impact that GLP-1 drugs

36,399 Shares of Global Partners LP $GLP Bought by Bank of America Corp DE
defenseworld.net
36,399 Shares of Global Partners LP $GLP Bought by Bank of America Corp DE

Bank of America Corp DE acquired a new position in shares of Global Partners LP (NYSE: GLP) in the s

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
cnbc.com
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s

Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in

Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
globenewswire.com
Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor

In a predefined MRI substudy, trevogrumab prevented 70% of muscle loss associated with semaglutide t

Should Value Investors Buy Global Partners (GLP) Stock?
zacks.com
Should Value Investors Buy Global Partners (GLP) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Lilly's oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease
prnewswire.com
Lilly's oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted

In post-hoc analyses of ATTAIN-1, Foundayo 17.2 mg was associated with a predicted 57% and 18% reduc

Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained A1C reduction and weight loss in its largest and longest type 2 diabetes study
prnewswire.com
Lilly's oral GLP-1, Foundayo (orforglipron), demonstrated cardiovascular safety alongside sustained

In ACHIEVE-4, participants taking Foundayo experienced a 16% lower risk of MACE-4 and a 23% lower ri

Solvonis says alcohol treatment outpaces GLP-1 drugs in cross-trial comparison
proactiveinvestors.com
Solvonis says alcohol treatment outpaces GLP-1 drugs in cross-trial comparison

Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) says new analysis of its ketamine-based alcohol trea

Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly?
fool.com
Could This Mid-Cap GLP-1 Stock Be a Better Buy Than Eli Lilly?

Eli Lilly's high valuation could limit the stock's future returns. Viking Therapeutics is a much sma

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
cnbc.com
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

Novo this week laid out an ambitious strategy to reignite growth beyond its top-selling Wegovy and O

benzinga.com
Global Partners Q2 EPS $1.86 Beats $1.24 Estimate, Sales $6.792B Miss $7.507B Estimate

Global Partners (NYSE:GLP) reported quarterly earnings of $1.86 per share which beat the analyst con

benzinga.com
Global Partners Q1 EPS $1.85 Beats $0.33 Estimate, Sales $5.322B Miss $6.976B Estimate

Global Partners (NYSE:GLP) reported quarterly earnings of $1.85 per share which beat the analyst con

benzinga.com
Stifel Maintains Hold on Global Partners, Raises Price Target to $46

Stifel analyst Selman Akyol maintains Global Partners (NYSE:GLP) with a Hold and raises the price

Global Partners: Q4 Earnings Insights
benzinga.com
Global Partners: Q4 Earnings Insights

Earnings Scheduled For February 27, 2026
benzinga.com
Earnings Scheduled For February 27, 2026

Nasdaq Down Over 1% As Nvidia Shares Fall: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
benzinga.com
Nasdaq Down Over 1% As Nvidia Shares Fall: Investor Sentiment Declines, Greed Index Moves To 'Fear'

Market sentiment declines, Nasdaq falls 1%. Nvidia down 5%, Salesforce up 4% in earnings. Initial jo

Dell, Block And 3 Stocks To Watch Heading Into Friday
benzinga.com
Dell, Block And 3 Stocks To Watch Heading Into Friday

U.S. stock futures lower, Carter's and Dell report earnings, Global Partners and Block announce

Preview: Global Partners's Earnings
benzinga.com
Preview: Global Partners's Earnings

benzinga.com
Stifel Maintains Hold on Global Partners, Lowers Price Target to $45

Stifel analyst Selman Akyol maintains Global Partners (NYSE:GLP) with a Hold and lowers the price

benzinga.com
Global Partners Q3 EPS $0.66 Misses $1.09 Estimate, Sales $4.694B Miss $7.211B Estimate

Global Partners (NYSE:GLP) reported quarterly earnings of $0.66 per share which missed the analyst c

Earnings Scheduled For November 7, 2025
benzinga.com
Earnings Scheduled For November 7, 2025

benzinga.com
A Look Ahead: Global Partners's Earnings Forecast

Top 3 Energy Stocks That May Rocket Higher In October
benzinga.com
Top 3 Energy Stocks That May Rocket Higher In October

Under the Radar: What Private Equity Really Does and How You Can Copy It
benzinga.com
Under the Radar: What Private Equity Really Does and How You Can Copy It

benzinga.com
Global Partners Q2 EPS $0.55 Misses $0.60 Estimate, Sales $4.627B Miss $5.985B Estimate

Global Partners (NYSE:GLP) reported quarterly earnings of $0.55 per share which missed the analyst c

benzinga.com
Earnings Scheduled For August 7, 2025

Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says
benzinga.com
Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says

U.S. stocks rallied Thursday after the Trump administration signed its first major trade agreement w

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For February 28, 2025

benzinga.com
Earnings Scheduled For February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

benzinga.com
Earnings Scheduled For August 4, 2023

Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first

benzinga.com
Earnings Scheduled For May 5, 2023

Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly e

benzinga.com
Earnings Scheduled For November 4, 2022

Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $

benzinga.com
Earnings Scheduled For February 28, 2022

  Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo

benzinga.com
Earnings Scheduled For November 5, 2021

  Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report ea

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    During Wednesday's morning trading, 251 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

    Tuesday morning saw 244 companies set new 52-week highs.

benzinga.com
70 Biggest Movers From Friday

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.

benzinga.com
56 Stocks Moving In Friday's Mid-Day Session

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.